Junqi He
10PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Mar 25, 2026
MAGI3 deficiency unleashes β-catenin conformational change to drive metastatic progression and mTOR inhibitor resistance in ccRCC.Siyu Gu, Haibo Wang, Hua Liu
|Feb 16, 2026
PDZK1-ULK1 Axis Triggers Lipophagy to Inhibit Tumor Progression and Sunitinib Resistance in Clear Cell Renal Cell Carcinoma.Xuan Qi, Yu Guo, Yumeng Yang
|Feb 28, 2025
Author Correction: A targetable OSGIN1-AMPK-SLC2A3 axis controls the vulnerability of ovarian cancer to ferroptosis.Mengqi Deng, Fan Tang, Xiangyu Chang
|Feb 16, 2025
MAGI3 enhances sensitivity to sunitinib in renal cell carcinoma by suppressing the MAS/ERK axis and serves as a prognostic marker.Haibo Wang, Yibin Chen, Ying Yang
|Jan 14, 2025
A targetable OSGIN1 - AMPK - SLC2A3 axis controls the vulnerability of ovarian cancer to ferroptosis.Mengqi Deng, Fan Tang, Xiangyu Chang
|May 31, 2024
PDZK1 confers sensitivity to sunitinib in clear cell renal cell carcinoma by suppressing the PDGFR-β pathway.Haibo Wang, Lijie Zhang, Hua Liu
Pageof 2
